VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PHIO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
PHIOPhio Pharmaceuticals Corp.
$0.80$9M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPHIOQuarterly Cash Flow

Phio Pharmaceuticals Corp. (PHIO) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Phio Pharmaceuticals Corp. (PHIO) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

PHIO Cash Flow Statement

Quarterly statement

PHIO Cash Flow Statement

Phio Pharmaceuticals Corp. (PHIO) cash flow statement — 15-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-2.28M-4.04M-4M-2.08M-2.08M-2.54M-1.27M-1.37M-1.95M-1.78M-2.01M-2.37M-2.9M-2.77M-2.71M-2.71M-3.53M-2.43M-3.47M-2.47M
Operating CF Margin %--------------------
Operating CF Growth %-9.35%-58.86%-213.96%-51.64%-6.76%-42.94%36.6%42.15%32.66%35.87%25.74%12.38%17.75%-14.08%21.94%-9.47%-23.03%25.38%-6.22%5.79%
Net Income-4.16M-4.14M-4M-2.37M-2.39M-2.17M-1.77M-1.63M-1.52M-1.85M-2.15M-1.9M-2.78M-2.55M-3.6M-2.73M-3.58M-2.53M-2.64M-3.45M
Depreciation & Amortization2K1K1K1K2K500042K01K34K43K47K47K47K46K46K49K52K137K
Stock-Based Compensation285K278K318K0113K51K43K48K52K15K32K9K89K94K111K0103K83K186K138K
Deferred Taxes000000000000-651K0000000
Other Non-Cash Items1.1M0-3K274K0-5000-51K003K126K651K0042K-605K046K-126K
Working Capital Changes492K-176K-316K17K192K-425K451K216K-481K53K74K-653K-256K-363K736K-62K506K-30K-1.11M831K
Change in Receivables00000000000000000000
Change in Inventory00000000000000000000
Change in Payables-15K641K-175K-80K281K-192K174K69K-151K15K-337K484K-468K-261K123K236K0819K00
Cash from Investing003K0-7K-3K-2K8K00000-5K00-7K-10K-104K0
Capital Expenditures0000-7K-3K-2K-1K00000-5K00-7K-10K-104K0
CapEx % of Revenue--------------------
Acquisitions0-3K3K00000000000000000
Investments--------------------
Other Investing03K000009K000000000000
Cash from Financing-107K0012.4M2.02M40K9.17M1.35M2.65M0-4K2.4M05.05M-38K2K-3K0-25K-1K
Debt Issued (Net)00000000000000000000
Equity Issued (Net)00012.4M2.05M40K9.17M1.36M2.65M0-4K2.4M05.05M-13K2K-3K0-25K-1K
Dividends Paid00000000000000000000
Share Repurchases00000000-1K0-4K000-13K0-3K0-25K-1K
Other Financing-107K000-30K00-1K000-1K00-25K00000
Net Change in Cash-2.39M-4.04M-4M10.33M-70K-2.5M7.9M-8K692K-1.78M-2.02M33K-2.9M2.27M-2.75M-2.7M-3.54M-2.44M-3.6M-2.47M
Free Cash Flow-2.28M-4.04M-4M-2.08M-2.09M-2.54M-1.28M-1.37M-1.95M-1.78M-2.01M-2.37M-2.9M-2.78M-2.71M-2.71M-3.53M-2.44M-3.57M-2.47M
FCF Margin %--------------------
FCF Growth %-8.99%-58.67%-213.47%-51.53%-7.12%-43.11%36.5%42.11%32.66%35.99%25.74%12.38%17.92%-13.82%24.21%-9.47%-22%25.41%-9.2%5.83%
FCF per Share-0.20-0.35-0.34-0.18-0.38-0.53-0.30-1.74-1.97-3.48-3.96-5.70-10.71-14.47-21.36-21.39-27.96-19.30-28.48-19.74
FCF Conversion (FCF/Net Income)0.55x0.98x1.00x0.88x0.87x1.17x0.72x0.84x1.28x0.96x0.93x1.25x1.04x1.09x0.75x0.99x0.99x0.96x1.31x0.72x
Interest Paid0000000003K1K000000000
Taxes Paid00000000000000000000